Phosphoramidites

N4-Benzoyl-2'-deoxy-5'-O-DMT-2'-fluoro-5-methylcytidine 3'-CE phosphoramidite

Description: N4-Benzoyl-2'-deoxy-5'-O-DMT-2'-fluoro-5-methylcytidine 3'-CE phosphoramidite, an essential ingredient employed in the biomedical sector, serves as a fundamental constituent in the synthesis of oligonucleotides. Its significance lies in its application for therapeutic drug development targeting an array of ailments, ranging from viral infections to cancer. By virtue of its adaptability, this product allows for the meticulous manipulation of DNA molecules, thereby enabling targeted drug administration and augmenting the efficacy of therapeutic interventions.

CAT: BRP-01992

CAS: 182495-83-6

Molecular Formula: C47H53FN5O8P

Molecular Weight: 865.92

Purity: >98%

Appearance: White to off-white powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: XYPAFCMPDQWTME-LVTIEWELSA-N

Solubility: Soluble in Acetonitrile, DMF

CanonicalSMILES: CC1=CN(C(=O)N=C1NC(=O)C2=CC=CC=C2)C3C(C(C(O3)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)OP(N(C(C)C)C(C)C)OCCC#N)F

IUPAC Name: N-[1-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-3-fluorooxolan-2-yl]-5-methyl-2-oxopyrimidin-4-yl]benzamide

InChI: InChI=1S/C47H53FN5O8P/c1-31(2)53(32(3)4)62(59-28-14-27-49)61-42-40(60-45(41(42)48)52-29-33(5)43(51-46(52)55)50-44(54)34-15-10-8-11-16-34)30-58-47(35-17-12-9-13-18-35,36-19-23-38(56-6)24-20-36)37-21-25-39(57-7)26-22-37/h8-13,15-26,29,31-32,40-42,45H,14,28,30H2,1-7H3,(H,50,51,54,55)/t40-,41-,42-,45-,62?/m1/s1

Synonyms: 2'-F MeC(Bz) amidite; Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-2'-fluoro-5-methyl-, 3'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite]; 2'-Fluoro-5MeC(Bz)-3'-phosphoramidite; 5-Me-N4-Bz-5'-O-DMT-2'-fluoro-2'-deoxy-cytidine 3'-CE phosphoramidite; N4-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-deoxy-2'-fluoro-5-methylcytidine-3'-O-[(2-cyanoethyl)(N,N-diisopropyl)]phosphoramidite; N4-Bz-5'-O-DMTr-2'-deoxy-2'-fluoro-5-methylcytidine-3'-CED phosphoramidite; N-Benzoyl-2'-deoxy-5'-O-DMT-2'-fluoro-5-methylcytidine 3'-CE phosphoramidite; DMT-2'-F-dC(Bz)-CE-Phosphoramidite

DMT-2'-F-dC(dmf)-CE-Phosphoramidite

Description: DMT-2'-F-dC(dmf)-CE-Phosphoramidite is a phosphoramidite compound used in the synthesis of modified oligonucleotides. This molecule is derived from deoxycytidine (dC) and features several modifications: a dimethoxytrityl (DMT) group at the 5' position, a fluorine atom at the 2' position, and a dimethylformamidine (dmf) protecting group on the exocyclic amino group of the cytosine base. The phosphoramidite group is attached to the 3' position, enabling its incorporation into synthetic DNA sequences. DMT-2'-F-dC(dmf)-CE-Phosphoramidite is particularly valuable in creating stable and effective oligonucleotides for diagnostic tools, therapeutic agents, and in studying nucleic acid interactions. The fluorine substitution at the 2' position also contributes to improved binding affinity and specificity in hybridization assays, making this compound a versatile tool in molecular biology and medical research.

CAT: BRP-02013

Molecular Formula: C42H52FN6O7P

Molecular Weight: 802.89

Purity: ≥98%

Appearance: White solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: LCASHFMAIHZMPJ-UAQIPLLRSA-N

Solubility: Soluble in Acetonitrile, DMF

CanonicalSMILES: CC(C)N(C(C)C)P(OCCC#N)OC1C(OC(C1F)N2C=CC(=NC2=O)N=CN(C)C)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC

IUPAC Name: N'-[1-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-3-fluorooxolan-2-yl]-2-oxopyrimidin-4-yl]-N,N-dimethylmethanimidamide

InChI: InChI=1S/C42H52FN6O7P/c1-29(2)49(30(3)4)57(54-26-12-24-44)56-39-36(55-40(38(39)43)48-25-23-37(46-41(48)50)45-28-47(5)6)27-53-42(31-13-10-9-11-14-31,32-15-19-34(51-7)20-16-32)33-17-21-35(52-8)22-18-33/h9-11,13-23,25,28-30,36,38-40H,12,26-27H2,1-8H3/t36-,38-,39-,40-,57?/m1/s1

Synonyms: (2R,3R,4R,5R)-2-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(4-(((dimethylamino)methylene)amino)-2-oxopyrimidin-1(2H)-yl)-4-fluorotetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite; 5'-O-DMT-N4-DMF-2'-fluoro-2'-deoxy-cytidine 3'-CE phosphoramidite; 2'-F C(DMF) amidite; 2'-Fluoro-C(DMF)-3'-phosphoramidite; N4-DMF-5'-O-DMT-2'-fluoro-2'-deoxy-cytidine 3'-CE phosphoramidite; N4-Dimethylformamidine-5'-O-(4,4'-dimethoxytrityl)-2'-deoxy-2'-fluorocytidine-3'-O-[(2-cyanoethyl)(N,N-diisopropyl)]phosphoramidite; N4-DMF-5'-O-DMTr-2'-deoxy-2'-fluorocytidine-3'-CED phosphoramidite; 2'-Fluoro-2'-Deoxycytidine(DMF)-CE Phosphoramidite; DMT-2'-Fluoro-dC(DMF) Phosphoramidite; 5'-O-DMTr-2'-F-dC(dmf)-3'-CE-Phosphoramidite; N4-Dimethylformamidine-5'-O-(4,4'-Dimethoxytrityl)-2'-fluoro-deoxycytidine-3'-cyanoethyl Phosphoramidite

DMT-2'-F-dG(dmf)-CE-Phosphoramidite

Description: DMT-2'-F-dG(dmf)-CE-Phosphoramidite is a phosphoramidite compound used in the synthesis of oligonucleotides. This molecule is derived from deoxyguanosine (dG) and is modified with a dimethoxytrityl (DMT) protecting group at the 5' position, a fluorine atom at the 2' position, and a dimethylformamidine (dmf) protecting group on the exocyclic amino group of the guanine base. The phosphoramidite group is attached to the 3' end, making it suitable for incorporation into synthetic DNA sequences during automated DNA synthesis. This compound is valuable in research and biotechnology for creating fluorinated oligonucleotides, which are often used to study nucleic acid interactions, improve the stability of DNA, and enhance the binding affinity to complementary strands. The 2'-fluoro modification provides increased resistance to nucleases, making the resulting oligonucleotides more stable in biological environments. The DMT protecting group facilitates the stepwise synthesis of oligonucleotides, and the CE (cyanoethyl) phosphoramidite chemistry is widely used for efficient and high-yield DNA synthesis. This compound is particularly useful in developing diagnostic tools, therapeutic agents, and exploring the structure-function relationships of nucleic acids.

CAT: BRP-02019

Molecular Formula: C43H52FN8O7P

Molecular Weight: 842.91

Purity: ≥98% by HPLC

Appearance: White powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: BUKKJOTXODUNQK-PKTARBJSSA-N

CanonicalSMILES: CC(C)N(C(C)C)P(OCCC#N)OC1C(OC(C1F)N2C=NC3=C2N=C(NC3=O)N=CN(C)C)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC

IUPAC Name: N'-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-3-fluorooxolan-2-yl]-6-oxo-1H-purin-2-yl]-N,N-dimethylmethanimidamide

InChI: InChI=1S/C43H52FN8O7P/c1-28(2)52(29(3)4)60(57-24-12-23-45)59-38-35(58-41(36(38)44)51-27-46-37-39(51)48-42(49-40(37)53)47-26-50(5)6)25-56-43(30-13-10-9-11-14-30,31-15-19-33(54-7)20-16-31)32-17-21-34(55-8)22-18-32/h9-11,13-22,26-29,35-36,38,41H,12,24-25H2,1-8H3,(H,48,49,53)/t35-,36-,38-,41-,60?/m1/s1

Synonyms: 2'-Fluoro-N2-dimethylformamidine-5'-O-(4,4'-dimethoxytrityl)-2'-deoxyguanosine-3'-CE Phosphoramidite; 2'-Fluoro-N2-dimethylformamidine-5'-O-DMT-2'-deoxyguanosine-3'-CE-Phosphoramidite; 5'-O-DMT-2'-fluoro-N2-dimethylformamidine-2'-Deoxy-guanosine 3'-CE phosphoramidite; DMT-2'-Fluoro-dG(DMF) Phosphoramidite

1-(2'-Deoxy-5'-O-DMT-2'-fluoro-b-D-arabinofuranosyl)thymine 3'-CE phosphoramidite

Description: 1-(2'-Deoxy-5'-O-DMT-2'-fluoro-β-D-arabinofuranosyl)thymine 3'-CE phosphoramidite is used in the solid-phase synthesis of modified oligonucleotides. The modifications enhance the stability and binding affinity of the oligonucleotides. These modified nucleotides are valuable in various applications, including the development of antisense oligonucleotides, siRNA, and other therapeutic nucleic acids, as well as in research settings where enhanced stability and specific interactions are required.

CAT: BRP-02028

CAS: 208193-48-0

Molecular Formula: C40H48FN4O8P

Molecular Weight: 762.82

Purity: 97%

Appearance: White to off-white foam solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: XUCJAZSCNJHDKP-HRYQFPRASA-N

Solubility: Soluble in Acetone, Chloroform, DMSO, Ethanol, Methanol

CanonicalSMILES: CC1=CN(C(=O)NC1=O)C2C(C(C(O2)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)OP(N(C(C)C)C(C)C)OCCC#N)F

IUPAC Name: 3-[[(2R,3R,4S,5R)-2-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-fluoro-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-3-yl]oxy-[di(propan-2-yl)amino]phosphanyl]oxypropanenitrile

InChI: InChI=1S/C40H48FN4O8P/c1-26(2)45(27(3)4)54(51-23-11-22-42)53-36-34(52-38(35(36)41)44-24-28(5)37(46)43-39(44)47)25-50-40(29-12-9-8-10-13-29,30-14-18-32(48-6)19-15-30)31-16-20-33(49-7)21-17-31/h8-10,12-21,24,26-27,34-36,38H,11,23,25H2,1-7H3,(H,43,46,47)/t34-,35+,36-,38-,54?/m1/s1

Synonyms: 5'-O-dimethoxytrityl-2'-deoxy-2'-fluoroarabinothymidine-3'-[(2-cyanoethyl)-(N,N-diisopropropyl)]-Phosphoramidite; 2'-F-ANA-T-3'-CE-Phosphoramidite; 5'-O-(4,4'-Dimethoxytrityl)-2'-deoxy-2'-fluoro-5-methyl-beta-D-arabinouridine-3'-CED-phosphoramidite; 1-[5-O-[Bis(4-methoxyphenyl)phenylmethyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-2-deoxy-2-fluoro-β-D-arabinofuranosyl]-5-methyl-2,4(1H,3H)-pyrimidinedione; 2'-Deoxy-2'-fluoro-5-Me-ara-U-3'-CED-phosphoramidite

Boc-PNA-T-OH

Description: Boc-PNA-T-OH is a thymine-containing peptide nucleic acid monomer that is protected with a Boc (tert-butyloxycarbonyl) group at the N-terminus. It has a free carboxyl group at the C-terminus, allowing for further chemical modifications or elongation during the synthesis of PNAs. This monomer is used in the synthesis of PNAs, which are designed to bind to complementary nucleic acid sequences with high specificity and stability, making them useful in genetic diagnostics, antisense therapies, and molecular biology research.

CAT: BRP-02042

CAS: 139166-80-6

Molecular Formula: C16H24N4O7

Molecular Weight: 384.39

Purity: 98%

Appearance: White to Off-white Powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

Density: 1.301±0.06 g/cm3

InChIKey: WOTJPRVGZZWRGT-UHFFFAOYSA-N

CanonicalSMILES: CC1=CN(C(=O)NC1=O)CC(=O)N(CCNC(=O)OC(C)(C)C)CC(=O)O

IUPAC Name: 2-[[2-(5-methyl-2,4-dioxopyrimidin-1-yl)acetyl]-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethyl]amino]acetic acid

InChI: InChI=1S/C16H24N4O7/c1-10-7-20(14(25)18-13(10)24)8-11(21)19(9-12(22)23)6-5-17-15(26)27-16(2,3)4/h7H,5-6,8-9H2,1-4H3,(H,17,26)(H,22,23)(H,18,24,25)

Synonyms: Boc-T-Aeg-OH; Glycine, N-[2-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)acetyl]-N-[2-[[(1,1-dimethylethoxy)carbonyl]amino]ethyl]-; Glycine, N-[(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)acetyl]-N-[2-[[(1,1-dimethylethoxy)carbonyl]amino]ethyl]-; N-[2-(3,4-Dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)acetyl]-N-[2-[[(1,1-dimethylethoxy)carbonyl]amino]ethyl]glycine; Boc-PNA-U(5-Me)-OH

Fmoc-PNA-C(Bhoc)-OH

Description: Fmoc-PNA-C(Bhoc)-OH is a cytosine-containing peptide nucleic acid (PNA) monomer that is protected with an Fmoc (fluorenylmethyloxycarbonyl) group at the N-terminus and a Bhoc (benzhydryloxycarbonyl) group protecting the cytosine base. Fmoc-PNA-C(Bhoc)-OH is a protected PNA monomer used in the synthesis of peptide nucleic acids, offering specificity for guanine binding, stability against enzymatic degradation, and strong hybridization properties. It is widely used in genetic diagnostics, antisense therapy, and various molecular biology applications.

CAT: BRP-02043

CAS: 186046-81-1

Molecular Formula: C39H35N5O8

Molecular Weight: 701.73

Purity: ≥95%

Appearance: White to off-white powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C

Density: 1.34±0.1 g/cm3

InChIKey: YPTOIRLDQISSCH-UHFFFAOYSA-N

CanonicalSMILES: C1=CC=C(C=C1)C(C2=CC=CC=C2)OC(=O)NC3=NC(=O)N(C=C3)CC(=O)N(CCNC(=O)OCC4C5=CC=CC=C5C6=CC=CC=C46)CC(=O)O

IUPAC Name: 2-[[2-[4-(benzhydryloxycarbonylamino)-2-oxopyrimidin-1-yl]acetyl]-[2-(9H-fluoren-9-ylmethoxycarbonylamino)ethyl]amino]acetic acid

InChI: InChI=1S/C39H35N5O8/c45-34(23-44-21-19-33(41-37(44)48)42-39(50)52-36(26-11-3-1-4-12-26)27-13-5-2-6-14-27)43(24-35(46)47)22-20-40-38(49)51-25-32-30-17-9-7-15-28(30)29-16-8-10-18-31(29)32/h1-19,21,32,36H,20,22-25H2,(H,40,49)(H,46,47)(H,41,42,48,50)

Synonyms: 2-(N-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-2-(4-(((benzhydryloxy)carbonyl)amino)-2-oxopyrimidin-1(2H)-yl)acetamido)acetic acid; Glycine, N-[[4-[[(diphenylmethoxy)carbonyl]amino]-2-oxo-1(2H)-pyrimidinyl]acetyl]-N-[2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethyl]-; N-[2-[4-[[(Diphenylmethoxy)carbonyl]amino]-2-oxo-1(2H)-pyrimidinyl]acetyl]-N-[2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethyl]glycine; Fmoc PNA-C(Bhoc)-OH; Fmoc-C(Bhoc)-Aeg-OH; PNA C Monomer

Fmoc-PNA-A(Bhoc)-OH

Description: Fmoc-PNA-A(Bhoc)-OH is an adenine-containing peptide nucleic acid (PNA) monomer that is protected with an Fmoc (fluorenylmethyloxycarbonyl) group at the N-terminus and a Bhoc (benzhydryloxycarbonyl) group protecting the adenine base. Fmoc-PNA-A(Bhoc)-OH is a protected PNA monomer used in the synthesis of peptide nucleic acids, offering specificity for thymine (or uracil) binding, stability against enzymatic degradation, and strong hybridization properties. It is widely used in genetic diagnostics, antisense therapy, and various molecular biology applications.

CAT: BRP-02044

CAS: 186046-82-2

Molecular Formula: C40H35N7O7

Molecular Weight: 725.75

Purity: ≥98% by HPLC

Appearance: White to off-white powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C

Density: 1.39±0.1 g/cm3

InChIKey: LVVQRXRVCLWIIO-UHFFFAOYSA-N

CanonicalSMILES: C1=CC=C(C=C1)C(C2=CC=CC=C2)OC(=O)NC3=C4C(=NC=N3)N(C=N4)CC(=O)N(CCNC(=O)OCC5C6=CC=CC=C6C7=CC=CC=C57)CC(=O)O

IUPAC Name: 2-[[2-[6-(benzhydryloxycarbonylamino)purin-9-yl]acetyl]-[2-(9H-fluoren-9-ylmethoxycarbonylamino)ethyl]amino]acetic acid

InChI: InChI=1S/C40H35N7O7/c48-33(46(22-34(49)50)20-19-41-39(51)53-23-32-30-17-9-7-15-28(30)29-16-8-10-18-31(29)32)21-47-25-44-35-37(42-24-43-38(35)47)45-40(52)54-36(26-11-3-1-4-12-26)27-13-5-2-6-14-27/h1-18,24-25,32,36H,19-23H2,(H,41,51)(H,49,50)(H,42,43,45,52)

Synonyms: 2-(N-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-2-(6-(((benzhydryloxy)carbonyl)amino)-9H-purin-9-yl)acetamido)acetic acid; Fmoc-A(Bhoc)-Aeg-OH; Fmoc PNA-A(Bhoc)-OH; Glycine, N-[[6-[[(diphenylmethoxy)carbonyl]amino]-9H-purin-9-yl]acetyl]-N-[2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethyl]-; PNA A Monomer; N-[2-[6-[[(Diphenylmethoxy)carbonyl]amino]-9H-purin-9-yl]acetyl]-N-[2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethyl]glycine; Fmoc-A-(Bhoc)-OH; Fmoc-PNA-adenine(Bhoc)-OH

Fmoc-PNA-G(Bhoc)-OH

Description: Fmoc-PNA-G(Bhoc)-OH is a guanine-containing peptide nucleic acid (PNA) monomer that is protected with an Fmoc (fluorenylmethyloxycarbonyl) group at the N-terminus and a Bhoc (benzhydryloxycarbonyl) group protecting the guanine base. Fmoc-PNA-G(Bhoc)-OH is a protected PNA monomer used in the synthesis of peptide nucleic acids, offering specificity for cytosine binding, stability against enzymatic degradation, and strong hybridization properties. It is widely used in genetic diagnostics, antisense therapy, and various molecular biology applications.

CAT: BRP-02045

CAS: 186046-83-3

Molecular Formula: C40H35N7O8

Molecular Weight: 741.75

Purity: ≥98% by HPLC

Appearance: White to off-white powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C

Density: 1.43±0.1 g/cm3

InChIKey: ZNHVLNAONKUINW-UHFFFAOYSA-N

CanonicalSMILES: C1=CC=C(C=C1)C(C2=CC=CC=C2)OC(=O)NC3=NC4=C(C(=O)N3)N=CN4CC(=O)N(CCNC(=O)OCC5C6=CC=CC=C6C7=CC=CC=C57)CC(=O)O

IUPAC Name: 2-[[2-[2-(benzhydryloxycarbonylamino)-6-oxo-1H-purin-9-yl]acetyl]-[2-(9H-fluoren-9-ylmethoxycarbonylamino)ethyl]amino]acetic acid

InChI: InChI=1S/C40H35N7O8/c48-32(46(22-33(49)50)20-19-41-39(52)54-23-31-29-17-9-7-15-27(29)28-16-8-10-18-30(28)31)21-47-24-42-34-36(47)43-38(44-37(34)51)45-40(53)55-35(25-11-3-1-4-12-25)26-13-5-2-6-14-26/h1-18,24,31,35H,19-23H2,(H,41,52)(H,49,50)(H2,43,44,45,51,53)

Synonyms: Glycine, N-[[2-[[(diphenylmethoxy)carbonyl]amino]-1,6-dihydro-6-oxo-9H-purin-9-yl]acetyl]-N-[2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethyl]-; N-[2-[2-[[(Diphenylmethoxy)carbonyl]amino]-1,6-dihydro-6-oxo-9H-purin-9-yl]acetyl]-N-[2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethyl]glycine; 2-[N-[2-(Fmoc-amino)ethyl]-2-[2-[[(benzhydryloxy)carbonyl]amino]-6-oxo-1H-purin-9(6H)-yl]acetamido]acetic Acid; Fmoc-G(Bhoc)-Aeg-OH; Fmoc PNA-G-(Bhoc)-OH; PNA G Monomer

Fmoc-PNA-T-OH

Description: Fmoc-PNA-T-OH is a protected peptide nucleic acid (PNA) monomer used in the synthesis of peptide nucleic acids, offering specificity for adenine binding, stability against enzymatic degradation, and strong hybridization properties. It is widely used in genetic diagnostics, antisense therapy, and various molecular biology applications.

CAT: BRP-02046

CAS: 169396-92-3

Molecular Formula: C26H26N4O7

Molecular Weight: 506.51

Purity: ≥98% by HPLC

Appearance: White to off-white powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C

Density: 1.368±0.06 g/cm3

InChIKey: REUYSHQBEXUIRY-UHFFFAOYSA-N

CanonicalSMILES: CC1=CN(C(=O)NC1=O)CC(=O)N(CCNC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24)CC(=O)O

IUPAC Name: 2-[2-(9H-fluoren-9-ylmethoxycarbonylamino)ethyl-[2-(5-methyl-2,4-dioxopyrimidin-1-yl)acetyl]amino]acetic acid

InChI: InChI=1S/C26H26N4O7/c1-16-12-30(25(35)28-24(16)34)13-22(31)29(14-23(32)33)11-10-27-26(36)37-15-21-19-8-4-2-6-17(19)18-7-3-5-9-20(18)21/h2-9,12,21H,10-11,13-15H2,1H3,(H,27,36)(H,32,33)(H,28,34,35)

Synonyms: Fmoc-T-Aeg-OH; PNA T Monomer; Fmoc-U(5-Me)-Aeg-OH; Glycine, N-[(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)acetyl]-N-[2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethyl]-; N-[2-(3,4-Dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)acetyl]-N-[2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethyl]glycine; 2-(N-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-2-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamido)acetic acid

Fmoc-PNA-U-OH

Description: Fmoc-PNA-U-OH is a protected peptide nucleic acid (PNA) monomer used in the synthesis of peptide nucleic acids, offering specificity for adenine binding, stability against enzymatic degradation, and strong hybridization properties. It is widely used in genetic diagnostics, antisense therapy, and various molecular biology applications.

CAT: BRP-02047

CAS: 959151-70-3

Molecular Formula: C25H24N4O7

Molecular Weight: 492.48

Purity: ≥95%

Appearance: Solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8 °C

Density: 1.398±0.06 g/cm3

InChIKey: SSDDNBIJABMEDZ-UHFFFAOYSA-N

CanonicalSMILES: C1=CC=C2C(=C1)C(C3=CC=CC=C32)COC(=O)NCCN(CC(=O)O)C(=O)CN4C=CC(=O)NC4=O

IUPAC Name: 2-[[2-(2,4-dioxopyrimidin-1-yl)acetyl]-[2-(9H-fluoren-9-ylmethoxycarbonylamino)ethyl]amino]acetic acid

InChI: InChI=1S/C25H24N4O7/c30-21-9-11-29(24(34)27-21)13-22(31)28(14-23(32)33)12-10-26-25(35)36-15-20-18-7-3-1-5-16(18)17-6-2-4-8-19(17)20/h1-9,11,20H,10,12-15H2,(H,26,35)(H,32,33)(H,27,30,34)

Synonyms: N-[2-(3,4-Dihydro-2,4-dioxo-1(2H)-pyrimidinyl)acetyl]-N-[2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethyl]glycine; Fmoc-U-Aeg-OH; 2-(N-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamido)acetic acid

BOC-PNA-DAP(Z)-OH

Description: BOC-PNA-DAP(Z)-OH is a diaminopurine (DAP)-containing peptide nucleic acid (PNA) monomer that is protected with a BOC (tert-butoxycarbonyl) group at the N-terminus and has a benzyloxycarbonyl (Z) protection on the exocyclic amine group of diaminopurine. BOC-PNA-DAP(Z)-OH is a protected PNA monomer used in the synthesis of peptide nucleic acids, offering enhanced binding affinity for thymine or uracil, stability against enzymatic degradation, and strong hybridization properties. It is widely used in genetic diagnostics, antisense therapy, and various molecular biology applications where higher binding strength is advantageous.

CAT: BRP-02048

CAS: 202343-73-5

Molecular Formula: C24H30N8O7

Molecular Weight: 542.54

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.43±0.1 g/cm3

InChIKey: FHGQSRLUXIVDFA-UHFFFAOYSA-N

CanonicalSMILES: CC(C)(C)OC(=O)NCCN(CC(=O)O)C(=O)CN1C=NC2=C(N=C(N=C21)N)NC(=O)OCC3=CC=CC=C3

IUPAC Name: 2-[[2-[2-amino-6-(phenylmethoxycarbonylamino)purin-9-yl]acetyl]-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethyl]amino]acetic acid

InChI: InChI=1S/C24H30N8O7/c1-24(2,3)39-22(36)26-9-10-31(12-17(34)35)16(33)11-32-14-27-18-19(28-21(25)30-20(18)32)29-23(37)38-13-15-7-5-4-6-8-15/h4-8,14H,9-13H2,1-3H3,(H,26,36)(H,34,35)(H3,25,28,29,30,37)

Synonyms: Boc-DAP(Z)-Aeg-OH; BOC-PNA-D(Z)-OH; Glycine, N-[[2-amino-6-[[(phenylmethoxy)carbonyl]amino]-9H-purin-9-yl]acetyl]-N-[2-[[(1,1-dimethylethoxy)carbonyl]amino]ethyl]-; N-[2-[2-Amino-6-[[(phenylmethoxy)carbonyl]amino]-9H-purin-9-yl]acetyl]-N-[2-[[(1,1-dimethylethoxy)carbonyl]amino]ethyl]glycine

BOC-PNA-thioU(PMB)-OH

Description: BOC-PNA-thioU(PMB)-OH is a protected peptide nucleic acid (PNA) monomer used in the synthesis of peptide nucleic acids, featuring thiouracil with a PMB protecting group for enhanced binding affinity to adenine. It provides stability against enzymatic degradation and strong hybridization properties, making it useful in genetic diagnostics, antisense therapy, and various molecular biology applications where higher binding strength and additional functionalization are advantageous.

CAT: BRP-02049

CAS: 253438-99-2

Molecular Formula: C23H30N4O7S

Molecular Weight: 506.57

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.29±0.1 g/cm3

InChIKey: HDKCTBBIWSKCEV-UHFFFAOYSA-N

CanonicalSMILES: CC(C)(C)OC(=O)NCCN(CC(=O)O)C(=O)CN1C=CC(=O)N=C1SCC2=CC=C(C=C2)OC

IUPAC Name: 2-[[2-[2-[(4-methoxyphenyl)methylsulfanyl]-4-oxopyrimidin-1-yl]acetyl]-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethyl]amino]acetic acid

InChI: InChI=1S/C23H30N4O7S/c1-23(2,3)34-22(32)24-10-12-26(14-20(30)31)19(29)13-27-11-9-18(28)25-21(27)35-15-16-5-7-17(33-4)8-6-16/h5-9,11H,10,12-15H2,1-4H3,(H,24,32)(H,30,31)

Synonyms: BOC-PNA-thioU(PMB)-AEG-OH; Boc-thioU(PMB)-OH; BOC-PNA-S(Pmb)-OH; Glycine, N-[2-[[(1,1-dimethylethoxy)carbonyl]amino]ethyl]-N-[[2-[[(4-methoxyphenyl)methyl]thio]-4-oxo-1(4H)-pyrimidinyl]acetyl]-; N-[2-[[(1,1-Dimethylethoxy)carbonyl]amino]ethyl]-N-[2-[2-[[(4-methoxyphenyl)methyl]thio]-4-oxo-1(4H)-pyrimidinyl]acetyl]glycine; N-(2-((tert-butoxycarbonyl)amino)ethyl)-N-(2-(2-((4-methoxybenzyl)thio)-4-oxopyrimidin-1(4H)-yl)acetyl)glycine

Fmoc-PNA-J(BOC)-OH

Description: Fmoc-PNA-J(BOC)-OH is a protected peptide nucleic acid (PNA) monomer used in the synthesis of peptide nucleic acids, featuring the synthetic J base with BOC protection for enhanced binding properties. It provides stability against enzymatic degradation and strong hybridization properties, making it useful in genetic diagnostics, antisense therapy, and various molecular biology applications where higher binding strength and additional functionalization are advantageous.

CAT: BRP-02050

CAS: 1095275-70-9

Molecular Formula: C30H33N5O8

Molecular Weight: 591.61

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.37±0.1 g/cm3

InChIKey: HKYCYPRKFVETLD-UHFFFAOYSA-N

CanonicalSMILES: CC(C)(C)OC(=O)NC1=NC=C(C(=O)N1)CC(=O)N(CCNC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24)CC(=O)O

IUPAC Name: 2-[2-(9H-fluoren-9-ylmethoxycarbonylamino)ethyl-[2-[2-[(2-methylpropan-2-yl)oxycarbonylamino]-6-oxo-1H-pyrimidin-5-yl]acetyl]amino]acetic acid

InChI: InChI=1S/C30H33N5O8/c1-30(2,3)43-29(41)34-27-32-15-18(26(39)33-27)14-24(36)35(16-25(37)38)13-12-31-28(40)42-17-23-21-10-6-4-8-19(21)20-9-5-7-11-22(20)23/h4-11,15,23H,12-14,16-17H2,1-3H3,(H,31,40)(H,37,38)(H2,32,33,34,39,41)

Synonyms: Fmoc-J-(BOC)-AEG-OH; N-[2-[2-[[(1,1-Dimethylethoxy)carbonyl]amino]-1,6-dihydro-6-oxo-5-pyrimidinyl]acetyl]-N-[2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethyl]glycine; N-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-N-(2-(2-((tert-butoxycarbonyl)amino)-6-oxo-1,6-dihydropyrimidin-5-yl)acetyl)glycine; 2-[2-(2-{[(tert-butoxy)carbonyl]amino}-6-oxo-1,6-dihydropyrimidin-5-yl)-N-[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)ethyl]acetamido]acetic acid

BOC-PNA-J(Z)-OH

Description: BOC-PNA-J(Z)-OH is a protected peptide nucleic acid (PNA) monomer used in the synthesis of peptide nucleic acids, featuring the synthetic J base with Z protection for enhanced binding properties. It provides stability against enzymatic degradation and strong hybridization properties, making it useful in genetic diagnostics, antisense therapy, and various molecular biology applications where higher binding strength and additional functionalization are advantageous.

CAT: BRP-02051

CAS: 163081-03-6

Molecular Formula: C23H29N5O8

Molecular Weight: 503.51

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.34±0.1 g/cm3

InChIKey: SNXJLIUIBYUYNG-UHFFFAOYSA-N

CanonicalSMILES: CC(C)(C)OC(=O)NCCN(CC(=O)O)C(=O)CC1=CN=C(NC1=O)NC(=O)OCC2=CC=CC=C2

IUPAC Name: 2-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethyl-[2-[6-oxo-2-(phenylmethoxycarbonylamino)-1H-pyrimidin-5-yl]acetyl]amino]acetic acid

InChI: InChI=1S/C23H29N5O8/c1-23(2,3)36-21(33)24-9-10-28(13-18(30)31)17(29)11-16-12-25-20(26-19(16)32)27-22(34)35-14-15-7-5-4-6-8-15/h4-8,12H,9-11,13-14H2,1-3H3,(H,24,33)(H,30,31)(H2,25,26,27,32,34)

Synonyms: BOC-J(Z)-AEG-OH; Glycine, N-[[1,4-dihydro-4-oxo-2-[[(phenylmethoxy)carbonyl]amino]-5-pyrimidinyl]acetyl]-N-[2-[[(1,1-dimethylethoxy)carbonyl]amino]ethyl]-; N-(2-(2-(((benzyloxy)carbonyl)amino)-6-oxo-1,6-dihydropyrimidin-5-yl)acetyl)-N-(2-((tert-butoxycarbonyl)amino)ethyl)glycine

G-clamp PNA Monomer

Description: Guanidino-G-Clamp-PNA is a specialized type of peptide nucleic acid (PNA) modified with a guanidino group and a stabilizing clamp structure. This modification enhances its binding affinity, stability, and specificity when targeting complementary nucleic acid sequences. It finds applications in genetic diagnostics, therapeutics, and various research areas where precise nucleic acid targeting is essential.

CAT: BRP-02052

CAS: 476667-31-9

Molecular Formula: C50H46N8O12

Molecular Weight: 950.96

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.42±0.1 g/cm3

InChIKey: AIWBXGLHDFKUCY-UHFFFAOYSA-N

CanonicalSMILES: C1=CC=C(C=C1)COC(=O)NC(=NCCOC2=CC=CC3=C2NC4=NC(=O)N(C=C4O3)CC(=O)N(CCNC(=O)OCC5C6=CC=CC=C6C7=CC=CC=C57)CC(=O)O)NC(=O)OCC8=CC=CC=C8

IUPAC Name: 2-[[2-[9-[2-[bis(phenylmethoxycarbonylamino)methylideneamino]ethoxy]-2-oxo-10H-pyrimido[5,4-b][1,4]benzoxazin-3-yl]acetyl]-[2-(9H-fluoren-9-ylmethoxycarbonylamino)ethyl]amino]acetic acid

InChI: InChI=1S/C50H46N8O12/c59-42(57(28-43(60)61)24-22-52-48(63)69-31-38-36-18-9-7-16-34(36)35-17-8-10-19-37(35)38)27-58-26-41-45(54-47(58)62)53-44-39(20-11-21-40(44)70-41)66-25-23-51-46(55-49(64)67-29-32-12-3-1-4-13-32)56-50(65)68-30-33-14-5-2-6-15-33/h1-21,26,38H,22-25,27-31H2,(H,52,63)(H,60,61)(H,53,54,62)(H2,51,55,56,64,65)

Synonyms: Guanidino-G-Clamp-PNA; N-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-N-(2-(9-(2-(2,3-bis((benzyloxy)carbonyl)guanidino)ethoxy)-2-oxo-2,10-dihydro-3H-benzo[b]pyrimido[4,5-e][1,4]oxazin-3-yl)acetyl)glycine; Glycine, N-[[9-[2-[[bis[[(phenylmethoxy)carbonyl]amino]methylene]amino]ethoxy]-1,2-dihydro-2-oxo-3H-pyrimido[5,4-b][1,4]benzoxazin-3-yl]acetyl]-N-[2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethyl]-

Fmoc-PNA-A(Boc)-OH

Description: Fmoc-PNA-A(Boc)-OH is a synthetic peptide nucleic acid (PNA) modified with Fmoc and Boc protecting groups, designed for precise synthesis and specific hybridization with complementary DNA or RNA sequences. It serves as a versatile tool in molecular biology and biomedical research, offering high specificity and stability in nucleic acid interactions.

CAT: BRP-02053

CAS: 511534-99-9

Molecular Formula: C31H33N7O7

Molecular Weight: 615.64

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.41±0.1 g/cm3

InChIKey: CQFVUKSSRZPFKA-UHFFFAOYSA-N

CanonicalSMILES: CC(C)(C)OC(=O)NC1=C2C(=NC=N1)N(C=N2)CC(=O)N(CCNC(=O)OCC3C4=CC=CC=C4C5=CC=CC=C35)CC(=O)O

IUPAC Name: 2-[2-(9H-fluoren-9-ylmethoxycarbonylamino)ethyl-[2-[6-[(2-methylpropan-2-yl)oxycarbonylamino]purin-9-yl]acetyl]amino]acetic acid

InChI: InChI=1S/C31H33N7O7/c1-31(2,3)45-30(43)36-27-26-28(34-17-33-27)38(18-35-26)14-24(39)37(15-25(40)41)13-12-32-29(42)44-16-23-21-10-6-4-8-19(21)20-9-5-7-11-22(20)23/h4-11,17-18,23H,12-16H2,1-3H3,(H,32,42)(H,40,41)(H,33,34,36,43)

Synonyms: Glycine, N-[[6-[[(1,1-dimethylethoxy)carbonyl]amino]-9H-purin-9-yl]acetyl]-N-[2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethyl]-; N-[2-[6-[[(1,1-Dimethylethoxy)carbonyl]amino]-9H-purin-9-yl]acetyl]-N-[2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethyl]glycine; N-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-N-(2-(6-((tert-butoxycarbonyl)amino)-9H-purin-9-yl)acetyl)glycine

Fmoc-PNA-C(Boc)-OH

Description: Fmoc-PNA-C(Boc)-OH is a synthetic peptide nucleic acid (PNA) modified with Fmoc and Boc protecting groups, designed for controlled synthesis and specific binding to complementary DNA or RNA sequences. It serves as a valuable tool in molecular biology, offering high specificity and stability in nucleic acid interactions and applications ranging from basic research to diagnostics and therapeutic development.

CAT: BRP-02054

CAS: 172405-61-7

Molecular Formula: C30H33N5O8

Molecular Weight: 591.61

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.35±0.1 g/cm3

InChIKey: XTXTTZCNVKRDDX-UHFFFAOYSA-N

CanonicalSMILES: CC(C)(C)OC(=O)NC1=NC(=O)N(C=C1)CC(=O)N(CCNC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24)CC(=O)O

IUPAC Name: 2-[2-(9H-fluoren-9-ylmethoxycarbonylamino)ethyl-[2-[4-[(2-methylpropan-2-yl)oxycarbonylamino]-2-oxopyrimidin-1-yl]acetyl]amino]acetic acid

InChI: InChI=1S/C30H33N5O8/c1-30(2,3)43-29(41)33-24-12-14-35(27(39)32-24)16-25(36)34(17-26(37)38)15-13-31-28(40)42-18-23-21-10-6-4-8-19(21)20-9-5-7-11-22(20)23/h4-12,14,23H,13,15-18H2,1-3H3,(H,31,40)(H,37,38)(H,32,33,39,41)

Synonyms: Glycine, N-[[4-[[(1,1-dimethylethoxy)carbonyl]amino]-2-oxo-1(2H)-pyrimidinyl]acetyl]-N-[2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethyl]-; N-[2-[4-[[(1,1-Dimethylethoxy)carbonyl]amino]-2-oxo-1(2H)-pyrimidinyl]acetyl]-N-[2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethyl]glycine; N-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-N-(2-(4-((tert-butoxycarbonyl)amino)-2-oxopyrimidin-1(2H)-yl)acetyl)glycine

Fmoc-PNA-G(Boc)-OH

Description: Fmoc-PNA-G(Boc)-OH is a synthetic peptide nucleic acid (PNA) modified with Fmoc and Boc protecting groups, designed for precise synthesis and targeted binding to complementary DNA or RNA sequences. It serves as a versatile tool in molecular biology, offering robustness, specificity, and applicability across various research and diagnostic fields.

CAT: BRP-02055

CAS: 1052677-90-3

Molecular Formula: C31H33N7O8

Molecular Weight: 631.64

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.46±0.1 g/cm3

InChIKey: JVIAXIMEDXKTSN-UHFFFAOYSA-N

CanonicalSMILES: CC(C)(C)OC(=O)NC1=NC2=C(C(=O)N1)N=CN2CC(=O)N(CCNC(=O)OCC3C4=CC=CC=C4C5=CC=CC=C35)CC(=O)O

IUPAC Name: 2-[2-(9H-fluoren-9-ylmethoxycarbonylamino)ethyl-[2-[2-[(2-methylpropan-2-yl)oxycarbonylamino]-6-oxo-1H-purin-9-yl]acetyl]amino]acetic acid

InChI: InChI=1S/C31H33N7O8/c1-31(2,3)46-30(44)36-28-34-26-25(27(42)35-28)33-17-38(26)14-23(39)37(15-24(40)41)13-12-32-29(43)45-16-22-20-10-6-4-8-18(20)19-9-5-7-11-21(19)22/h4-11,17,22H,12-16H2,1-3H3,(H,32,43)(H,40,41)(H2,34,35,36,42,44)

Synonyms: N-[2-[2-[[(1,1-Dimethylethoxy)carbonyl]amino]-1,6-dihydro-6-oxo-9H-purin-9-yl]acetyl]-N-[2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]ethyl]glycine; N-(2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-N-(2-(2-((tert-butoxycarbonyl)amino)-6-oxo-1,6-dihydro-9H-purin-9-yl)acetyl)glycine; 2-(N-(2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)ethyl)-2-(2-((tert-butoxycarbonyl)amino)-6-oxo-1H-purin-9(6H)-yl)acetamido)acetic acid

Boc-PNA-U-OH

Description: Boc-PNA-U-OH is a synthetic peptide nucleic acid (PNA) modified with the Boc protecting group, designed for controlled synthesis and targeted binding to complementary DNA or RNA sequences. It serves as a versatile tool in molecular biology research, offering high specificity and utility across various applications in gene regulation, diagnostics, and nucleic acid research.

CAT: BRP-02056

CAS: 149500-74-3

Molecular Formula: C15H22N4O7

Molecular Weight: 370.36

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.335±0.06 g/cm3

Melting Point: 164-170 °C

InChIKey: ZPRZPMGSCWEHKC-UHFFFAOYSA-N

CanonicalSMILES: O=C(OC(C)(C)C)NCCN(C(=O)CN1C=CC(=O)NC1=O)CC(=O)O

IUPAC Name: N-(2-((tert-butoxycarbonyl)amino)ethyl)-N-(2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetyl)glycine

InChI: InChI=1S/C15H22N4O7/c1-15(2,3)26-14(25)16-5-7-18(9-12(22)23)11(21)8-19-6-4-10(20)17-13(19)24/h4,6H,5,7-9H2,1-3H3,(H,16,25)(H,22,23)(H,17,20,24)

Synonyms: Glycine, N-[(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)acetyl]-N-[2-[[(1,1-dimethylethoxy)carbonyl]amino]ethyl]-; N-[2-(3,4-Dihydro-2,4-dioxo-1(2H)-pyrimidinyl)acetyl]-N-[2-[[(1,1-dimethylethoxy)carbonyl]amino]ethyl]glycine

Boc-PNA-M(Z)-OH

Description: Boc-PNA-M(Z)-OH is a PNA monomer with a Boc protecting group on the terminal amine and a Cbz protecting group on the modified base. It is used in the synthesis of peptide nucleic acids (PNAs). The Boc group facilitates solid-phase synthesis by protecting the amine group, while the Z group protects the base during chemical reactions.

CAT: BRP-02057

Molecular Formula: C24H30N4O7

Molecular Weight: 486.53

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

InChIKey: CXZDUTOZNUXMQC-UHFFFAOYSA-N

CanonicalSMILES: O=C(O)CN(C(CC1=CC=C(NC(OCC2=CC=CC=C2)=O)N=C1)=O)CCNC(OC(C)(C)C)=O

IUPAC Name: N-(2-(6-(((benzyloxy)carbonyl)amino)pyridin-3-yl)acetyl)-N-(2-((tert-butoxycarbonyl)amino)ethyl)glycine

InChI: InChI=1S/C24H30N4O7/c1-24(2,3)35-22(32)25-11-12-28(15-21(30)31)20(29)13-18-9-10-19(26-14-18)27-23(33)34-16-17-7-5-4-6-8-17/h4-10,14H,11-13,15-16H2,1-3H3,(H,25,32)(H,30,31)(H,26,27,33)

N4-Benzoyl-2'-deoxy-5'-O-DMT-2'-fluoro-5-methylcytidine 3'-CE phosphoramidite

DMT-2'-F-dC(dmf)-CE-Phosphoramidite

DMT-2'-F-dG(dmf)-CE-Phosphoramidite

1-(2'-Deoxy-5'-O-DMT-2'-fluoro-b-D-arabinofuranosyl)thymine 3'-CE phosphoramidite

Boc-PNA-T-OH

Fmoc-PNA-C(Bhoc)-OH

Fmoc-PNA-A(Bhoc)-OH

Fmoc-PNA-G(Bhoc)-OH

Fmoc-PNA-T-OH

Fmoc-PNA-U-OH

BOC-PNA-DAP(Z)-OH

BOC-PNA-thioU(PMB)-OH

Fmoc-PNA-J(BOC)-OH

BOC-PNA-J(Z)-OH

G-clamp PNA Monomer

Fmoc-PNA-A(Boc)-OH

Fmoc-PNA-C(Boc)-OH

Fmoc-PNA-G(Boc)-OH

Boc-PNA-U-OH

Boc-PNA-M(Z)-OH

Our Products

Liposome Products

MicroRNA Products

mRNA Products

siRNA Products

RNA Synthesis Reagents

Cap Analogs

CPGs for Oligo Synthesis

Nucleosides

Nucleotides

Phosphoramidites